Efficacy and complications of neurosurgical treatment of acromegaly

Pituitary

Volumn 14, Issue 2, 2011, Pages 157-162

  Krzentowska Korek, Anna ^a   Gołkowski, Filip ^a   Bałdys Waligórska, Agata ^a   Hubalewska Dydejczyk, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acromegaly; GH; Hypopituitarism; IGF 1; Neurosurgery; Pituitary

Indexed keywords

FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADENOHYPOPHYSIS; ADULT; ARTICLE; CANCER INVASION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES INSIPIDUS; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOPHYSIS DISEASE; HYPOPHYSIS TUMOR; HYPOPITUITARISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; NEUROSURGERY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ACROMEGALY; ADENOMA; ADULT; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 79958135906     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-010-0273-0     Document Type: Article

References (25)

1. Holdaway IM, Rajasoorya C (1999) Epidemiology of acromegaly. Pituitary 2:29-41
2. Mestron A, Webb SM, Astorga R et al (2004) Epidemiology clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish acromegaly registry (Registro Espaňol de Acromegalia, REA). Eur J Endocrinol 151:439-446 (Pubitemid 39430260)
3. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr Rev 25:102-152 (Pubitemid 38269977)
4. Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86:2935-2941 (Pubitemid 32673444)
5. Jenkins PJ (2006) Cancers associated with acromegaly. Neuroendocrinology 83:218-223
6. Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G (2008) Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol 14:3484-3489
7. Loeper S, Ezzat S (2008) Acromegaly: rethinking the cancer risk. Rev Endocrinol Metab Disord 9:41-58
8. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly; a retrospective cohort study. United Kingdom acromegaly study group. J Clin Endocrinol Metab 83:2730-2734 (Pubitemid 28493768)
9. Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667-674 (Pubitemid 38269875)
10. Giustina A, Barkan A, Casanueva FF et al (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529 (Pubitemid 32273628)
11. Chanson P, Salenave S (2008) Acromegaly. Orphanet J Rare Dis 25:17
12. Lüdecke DK, Abe T (2006) Transsphenoidal microsurgery for newly diagnosed acromegaly: A personal view after more than 1,000 operations. Neuroendocrinology 83:230-239 (Pubitemid 44578877)
13. Melmed S, Casaneuva FF, Cavagnini F et al (2002) Consensus. Guidelines for acromegaly management. J Clin Endocrinol Metab 87:4054-4058
14. Freda PU, Wardlaw Sl, Post KD (1998) Long-term endocrinologic follow-up after transsphenoidal surgery for acromegaly. J Neurosurg 89:353-358 (Pubitemid 28405246)
15. Nomikos P, Buchfelder M, Fahlbush R et al (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical "cure". Eur J Endocrinol 152:379-387
16. Swearingen B, Barker FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zevas NT (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426 (Pubitemid 28500866)
17. Barker FG, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88:4709-4719 (Pubitemid 37357516)
18. Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225-236
19. Salaun C, Foubert L, Vialatou M, Kujas M, Turpin G (1999) Prognostic factors in the surgical management of acromegaly. Ann Med Intern 150:195-198 (Pubitemid 29350088)
20. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West midlands prospective hypopituitary study group. Lancet 357:425-431 (Pubitemid 32156141)
21. Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288 (Pubitemid 20229130)
22. Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM(2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 94:4216-4223
23. Leach P, Abou-Zeid AH, Kearney T, Davis J, Trainer PJ, Gnanalingham KK (2010) Endoscopic transsphenoidal pituitary surgery: evidence of an operative learning curve. Neurosurgery 67:1205-1212
24. Gondim JA, Alemida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T (2010) Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus 39(4):1-6 doi:10.3171/2010.7.FOCUS10167
25. Rieger A, Rainov NG, Ebel H, Sanchin L, Shibib K, Helfrich C, Hoffmann O, Burkert W (1997) Factors predicting pituitary adenoma invasiveness in acromegalic patients. Neurosurg Rev 20:182-187 (Pubitemid 27362364)